Abstract-Nanostructured biosensors with the aim of electroactive cancer-drug detection were investigated. The aim of this work is improvement of the sensitivity and limit of detection of two differently nanostructured biosensors to find out the best choice for quantifying the concentration of etoposide, as a widely used electroactive cancer drug, in its therapeutic range. To this purpose etoposide concentrations, ranging from zero to 60 μM, were sensed at multi-walled carbon nanotube and gold nanoparticle functionalized bioelectrodes using cyclic voltammetry. The optimum scan rate for voltammetric experiments was found out equal to 70 mV s -1 and 130 mV s -1 for multi-walled carbon nanotube and gold nanoparticle based electrodes, respectively. For nanostructuring the electrodes, the optimum nanomaterial mass were experimentally obtained for multi-walled carbon nanotube and gold nanoparticle based electrodes equal to 20 μg (4314 mm 2 of additional electroactive surface area) and 104 μg (6471 mm 2 of additional electroactive surface area), respectively. Bioelectrodes produced based on this optimized configurations showed sensitivity of 0.98 ± 0.41 μA μM -1 cm -2 and 1.43 ± 0.26 μA μM -1 cm -2 , and limit of detection of 1.52 ± 0.89 μM and 1.29 ± 0.48 μM for multi-walled carbon nanotube and gold nanoparticles based electrodes. Comparing the limit of detection achieved in this work with the therapeutic range of etoposide verifies the possibility of using both nanostructured bioelectrodes for etoposide detection. However, gold nanoparticle based electrodes exhibit better electrochemical improvements in terms of both sensitivity and limit of detection.
I. INTRODUCTION
Electrochemical metabolite detection using nanostructured bioelectrodes as sensing element are very attractive for point of care therapeutic drug monitoring (TDM), or in other words the individualization of the dosing regime to maintain the blood drug concentration within a beneficiary range that is called therapeutic range. This is more significant for cancer drugs, which are mainly toxics, and have normally very narrow therapeutic ranges; prescribing a dosing regime for them, as a result, for a wide range of patients with different genetic profile and cultural background is very difficult. Others have investigated the effectiveness of the TDM in terms of the additional costs (time and money) of the process in reducing the mortality and morbidity of the diseases [1] . This shows the need for a low cost and fast TDM process, which also ensures the good enough communication between the TDM team members for better interpretation of the results [2] [3] [4] . Electrochemical bioelectrodes have shown to be a promising system to replicate the time-consuming and costly laboratory experiments and analysis that are used for TDM, currently. Therefore, they can be the connection between TDM and site testing, emergency room screening, bedside monitoring and home self-testing [5] [6] . Electrochemical bioelectrodes provide an interface between redox site of target metabolite and electronic part of the biosensors. Most bioelectrodes act as transducers to convert biological events to electric current by applying a fixed potential over the electrode and target (amperometry), or sweeping the applied potential in a range (voltammetry) and measuring the current. Amperometry experiments are beneficial because of their high sensitivity and large linear range, whilst voltammetry experiments provide the option of multi-target detection [7] . Many different enzymatic [3] [9] [10] and non-enzymatic [10] [11] [12] bioelectrodes have been proposed in literature that can be useful to this purpose. The role of nanostructuring in enhancing the electrochemical performance of bioelectrodes is widely studied and reported [13] [14] [15] , but at our best knowledge there are not enough work done on the impact of physical nature of the different nanomaterials on the performance. The different effect of multi-walled carbon nanotubes (MWCNTs) and gold nanoparticles (GNPs) on enhancing the sensitivity and limit of detection (LOD) of H 2 O 2 -bioelectrodes is investigated somewhere else [16] . Similarly, direct electron transfer by enzymes has been investigated on MWCNT [17] and GNPs [9] . Moreover, nanoparticles are well know to support quantum phenomena both in case of conductive [18] and semiconductives ones [19] . The aim of this work is to compare and investigate the natural properties of the MWCNTs and GNPs on improving the performance of bioelectrodes for electroactive-drug detection. The optimum performance by means of each nanomaterial is obtained by modifying the additional ElectroActive Surface Areas (EASA) and scan rate of voltammetry experiments. Then the sensitivity of produced bioelectrodes with these optimized configurations are compared to figure out which one can be the better choice for biosensing applications.
II. MATERIAL AND METHODS

A. Nano materials
Biosensors were fabricated based on commercial screenprinted electrodes (SPEs) manufactured by Metrohm (DRP−110). They consist of graphite working electrode (area -0.12 cm 2 ), graphite counter electrode and silver reference electrode. Powder of MWCNTs (diameter: 10 nm; length: 1 to 2 μm; 90% purity), functionalized with COOH was purchased from DropSens (Spain), which was dispersed in chloroform to the concentration of 1 mg mL -1 , and was sonicated for 1 hour to achieve a homogenous solution. Dispersion of hydrophilic Gold nanoparticles (GNPs; OD-1; 0.06 mg mL -1 ), functionalized with Tannic acid, with average diameter of 5.22 ± 0.01 nm ( Fig. 2 ) was purchased from Sigma-Aldrich. Phosphate buffer saline (PBS-100mM; pH-7.4) was provided by Sigma-Aldrich, and solved in distilled water and stirred to obtain the homogenous solution. It was used as supporting electrolyte in experiments. Etoposide powder was purchased from Sigma-Aldrich and was dissolved in dimethyl sulfoxide (DMSO) to the concentration of 10 mM.
B. Electrode preparation
Functionalization of SPEs with nanostructures was carried out exploiting drop-casting technique for ease of action and minimizing the interferences. For instance, to prepare SPEs equipped with hydrophilic GNPs (GNP-SPEs), 290 μl of 0.06 mg mL -1 stock dispersion was dropped over the working electrode (W.E.) in steps of 10 μl to obtain overall mass of 17.4 μg of GNPs. Electrodes were stored at ambient temperature after each deposition for drying, and also for storage. Electroactive surface areas (EASA) have been calculated using specific surface area of each material and amount of deposited mass used for electrode preparation [20] . EASA has been used as the unit rather than mass to provide reasonable comparison between electrodes equipped with different types of nanomaterials, following the previous work of this group [16] . For scan rate optimization 3 electrodes were equipped with the optimized amount of MWCNTs (30 μg -6471 mm 2 of EASA) and GNPs (69.6 μg -4314 mm 2 of EASA). To optimize the amount of nanomaterial used for deposition (deposition mass optimization), 3 sets of electrodes were produced. Each set contained 9 electrodes equipped with MWCNTs ranging from 0 to 40 μg with step of 5 μg (bare SPE, MWCNT-SPE-1078, MWCNT-SPE-2157, …, MWCNT-SPE-8628). Next, same process were done to prepare 3 sets of GNP-SPEs (bare SPE, GNP-SPE-1078, …, GNP-SPE-8628). For instance, 17.4 μg of GNPs were deposited over W.E. of an electrode to produce GNP-SPE-1078. TEM (Fig. 2 ) and SEM images (Fig. 1) have been taken using Tecnai Osiris device, and MERLIN device, respectively. All image analyses have been performed utilizing ImageJ software [21] .
C. Electrochemical measurement apparatus and setup
Autolab potentiostat/galvanostat (PGSTAT128N) was used for cyclic voltammetry (CV) under aerobic conditions. To obtain the Voltammograms, first 100 μl of etoposide solution (PBS; pH-7.4; as background electrolyte) covered the active part of the electrode. Device was configured to swap the voltage between -1 and +1 for 10 cycles to achieve a stable result.
III. ELECTROCHEMICAL EXPERIMENTS AND RESULTS
Electrochemical experiments started with two optimization steps: first, to figure out the best protocol for electrode preparation in terms of the amount of mass for deposition. Second, to find out the optimum scan rate used in voltammetry experiments in order to get highest peak amplitude. 
A. MWCNT-SPEs optimization
To find out the best scan rate for CV the deposition mass was fixed to 6471 mm 2 (30 μg of MWCNTs). Concentration of etoposide in the target solution was set to 70 μM at this step (Etop-70). Three electrodes were prepared with this configuration and were tested using CV while varying the scan rate in a range of 10 mV s -1 to 120 mV s Acquired voltammograms (data not shown) have been analyzed by Nova software to obtain the measured peak amplitudes (Fig. 3) . Based on these data, scan rate of 70 mV s -1 can provide highest peak amplitude for MWCNT-SPEs. This scan rate has been used for next optimization step and sensitivity experiments of MWCNT-SPEs. At second optimization step, MWCNT-SPEs were prepared with EASA ranging from zero (bare-SPE) to 8628 mm 2 as explained earlier, and practiced by CV to detect Etop-70. Scan rate of CV experiment was fixed to the result of the last step (70 mV s -1 ). After analyzing the results the average of peak amplitudes are presented in Fig. 4 . SPEs equipped with 4314 mm 2 of additional EASA have exhibited highest peak amplitude. As a result, this deposition configuration and 70 mV s -1 as scan rate was used for MWCNTs-SPEs sensitivity experiments.
B. GNP-SPEs optimization
Scan rate and deposition mass optimization for GNP-SPEs were carried out with the same process as described for MWCNT-SPEs. The only differences were the deposited EASA (4314 mm 2 ) and the maximum tested scan rate (150 mV s -1 ) for scan rate optimization of GNP-SPEs. Acquired averaged peak amplitudes for scan rate and EASA optimizations are presented in Fig. 5 and Fig. 6 respectively. The scan rate extension to 150 mV s -1 was due to the fact that the peak was growing until 130 mV s and 6471 mm 2 were chosen for GNP-SPE as experiment and electrode preparation configurations.
C. Sensitivity and limit of detection comparison
To compare the MWCNT-SPEs and GNP-SPEs in terms of sensitivity and LOD, three electrodes were produced for each nanomaterial using optimum additional EASA and tested by CV using optimum scan rate configuration. Concentration of target solution, etoposide (PBS as background solution), was increased from 0 (blank measurement) to 60 μM in steps of 10 μM, corresponding to the therapeutic range of etoposide [22] . Acquired voltammograms related to the experiments performed on MWCNT-SPEs and hydrophilic GNP-SPEs are not shown here. Peak amplitudes were analyzed and measured for different concentrations of etoposide to obtain calibration curve. LODs were calculated using the standard deviation of three blank measurements related to each set of MWCNTSPEs and GNP-SPEs [23] . Calibration curves and measured data related to sensitivity and LODs are presented in Fig. 7 and Table 1 respectively. Presented data shows better performance for GNP-SPEs in terms of either sensitivity or LOD. Figure 7 , Calibration curves related to GNP-SPEs and MWCNT-SPEs are presented in this figure for comparison. These electrodes were prepared using 6471 and 4314 mm 2 of additional EASA respectively, and were experimented with CV to detect etoposide with concentration varying from 0 to 60 μM as is shown on the horizontal axis. Scan rates were set to 130 and 70 mVs -1 , respectively. Data points are shifted, to provide more clarity of sensitivity differences, by 2.95 μA and 1.2 μA for MWCNT-SPEs and GNP-SPEs respectively.
IV. CONCLUSION
Better electrochemical properties of GNP-SPEs (5 nm in diameter) respect to MWCNT-SPEs (higher sensitivity and better LOD) on detection of etoposide are experimentally proven. This enhancement is partly owing to higher affinity of hydrophilic GNPs to electroactive xenobiotics as etoposide, and partly due to the small dimension of nanoparticles. Taking into account that both functionalized electrodes were tested at their optimum configurations, it can be inferred that the size of nanoparticles that is under the 10 nm have taken a significant role. This is already discussed that GNPs with decreasing diameter can provide electrochemical enhancements. For instance, in [24] it is presented that by decreasing the size of GNPs from 13 nm to 6 nm and then to 3.5 nm, maximum current is increased to 66.2 μA, 73.8 μA, and 76.2 μA, respectively. However, this phenomenon is not observed experimentally on electroactive drug detection. Low enough LOD, high sensitivity (even at very low concentrations) and simple functionalization make the proposed GNP-SPEs a suitable option for detection of electroactive drugs as etoposide. Nevertheless, there are some other factors to be addressed including the effect of nanoparticles dimension on the performance and the physics behind it, which is the target of this group future works. V. ACHNOWLEDGEMENT 
